2021 MIPS Measure #395: Lung Cancer Reporting (Biopsy/Cytology Specimens) 

Measure Type High Priority Measure? Collection Type(s)
Process yes Medicare Part B Claims, MIPS CQM


Measure Description

Pathology reports based on biopsy and/or cytology specimens with a diagnosis of primary non-small cell lung cancer classified into specific histologic type or classified as NSCLC-NOS with an explanation included in the pathology report